Skip to main content

Verona Pharma Plc ADR(VRNA-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update

Globe Newswire - Tue May 3, 2022

Phase 3 ENHANCE-2 trial on target to report top-line COPD data in Q3 2022

James Brady joined the Board as Non-Executive Director

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

opinion
Four reasons why wealthy investors should hold farmland in their portfolios
Andrea Gruza